Daily Health Headlines

Hormone-Like Drug Doesn't Help Women With Alzheimer's: Study

👤by Kathleen Doheny 0 comments 🕔Thursday, November 5th, 2015

WEDNESDAY, Nov. 4, 2015 (HealthDay News) -- The drug raloxifene doesn't help the declining memory and thinking skills of women who have mild to moderate dementia due to Alzheimer's disease, a small study suggests.

"We found no effect," said study researcher Dr. Victor Henderson, professor of health research and policy and neurology and neurological sciences at Stanford University in California.

Raloxifene is a complex drug. It acts like the female hormone estrogen in some parts of the body, while it blocks the effects of estrogen in the breasts and uterus, the study authors explained.

The researchers decided to look at the drug after another study of raloxifene, which is also used to treat the bone-thinning disease osteoporosis, found that the drug reduced the risk of healthy women developing impairments in their thinking and memory, Henderson said.

The new study, published online Nov. 4 in Neurology, included 42 women who were recruited between 2006 and 2009 from several sites across the United States. The study participants, aged 68 to 84, all had late-onset Alzheimer's disease that was in the mild to moderate stages.

The women were randomly assigned to take raloxifene or an inactive placebo pill for a year. The researchers tested the women's memory and other mental functions at the start of the study and every three months after that.

Test scores didn't differ significantly between the two groups, the investigators found. The scores didn't differ for memory and thinking skills, or how well the women could perform activities of daily living such as dressing themselves and other routines.

However, because the number of women in the study was so small, with only 21 women receiving treatment with raloxifene, "this study can't exclude a small effect," Henderson said.

In addition, the findings don't rule out that other drugs similar to raloxifene might have a benefit on thinking and memory, Henderson said. Raloxifene belongs to a class of drugs known as SERMs (selective estrogen receptor modulators). "The SERMs don't all act in the same way," he said.

"What this study shows," said Heather Snyder, senior director of medical and scientific operations for the Alzheimer's Association, "is that in this population, they don't see a big benefit" with raloxifene.

However, she added, scientists are still trying to understand the genetic and biological reasons for Alzheimer's, including hormonal pathways.

"I think there are a lot of things we don't understand about the underlying biology and the role of these different pathways for Alzheimer's disease," she said.

About 5 million Americans are living with Alzheimer's disease, according to the Alzheimer's Association, although not all are diagnosed. Of those, two-thirds are women, Snyder said, "but we don't know why."

Women's generally longer life expectancy may be one factor, but there may also be biological and genetic reasons, Snyder said.

Some of Henderson's co-researchers report serving as consultants or speakers for Eli Lilly, which provided the study drug, and other pharmaceutical companies. The U.S. National Institutes of Health supported the study.

Article Credits / Source

Kathleen Doheny / HealthDay

Kathleen Doheny wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Victor Henderson, M.D., professor of health research and policy and neurology and neurological sciences, Stanford University, Stanford, Calif.; Heather Snyder, Ph.D., senior director of medical and scientific operations, Alzheimer's Association, Chicago; Nov. 4, 2015, Neurology, online

View More Articles From Kathleen Doheny 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Alzheimer's Disease Articles

Fewer Americans Suffering From Dementia, Study Finds

Fewer Americans Suffering From Dementia, Study Finds0

MONDAY, Nov. 21, 2016 (HealthDay News) -- Here's some good news for America's seniors: Dementia rates have dropped dramatically over the last decade or so, according to a new study. An analysis of responses from a study of more than 10,000 ...

Can Occupational Therapy Slow Alzheimer's Decline?

Can Occupational Therapy Slow Alzheimer's Decline?0

MONDAY, Nov. 21, 2016 (HealthDay News) -- Home-based occupational therapy may not slow down the physical decline that comes with Alzheimer's disease, a new clinical trial suggests. The study looked at whether home visits from occupational ...

Poor Sense of Smell May Signal Alzheimer's Risk

Poor Sense of Smell May Signal Alzheimer's Risk0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A person's sense of smell may help predict their risk for Alzheimer's disease, a new study suggests. The researchers included 183 older people, and 10 had possible or probable Alzheimer's disease, ...

Some Elderly With Alzheimer's Brain Plaques Stay Sharp

Some Elderly With Alzheimer's Brain Plaques Stay Sharp0

MONDAY, Nov. 14, 2016 (HealthDay News) -- In a discovery that challenges conventional thinking, researchers report that several people over the age of 90 had excellent memory even though their brains showed signs that they had Alzheimer's ...

Brain Scans May Improve Dementia Diagnosis, Treatment

Brain Scans May Improve Dementia Diagnosis, Treatment0

TUESDAY, Nov. 8, 2016 (HealthDay News) -- Tens of millions of people worldwide suffer from memory loss and mental impairment due to dementia. While there's no cure, medication may temporarily improve some symptoms. Proper treatment, however, depends ...

View More Alzheimer's Disease Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!